Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model Meeting Abstract
| Authors: | Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; Ladanyi, M.; Somwar, R. |
| Abstract Title: | Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model |
| Meeting Title: | 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 174 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Oct 26-28 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S27 |
| Language: | English |
| ACCESSION: | WOS:000876973400065 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(22)01063-2 |
| Notes: | Meeting Abstract: 78 (PB068) -- In Poster Session "Molecular Targeted Agents 1" -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work